Home » Topics » Regulatory » EMA

EMA
RSS

FDA recommends further naproxcinod trials in complete response letter to NicOx

July 22, 2010

Global registrational trial announced for rFVIIIFc in hemophilia A

July 12, 2010

EMA commences review of rosiglitazone-containing medicines

July 12, 2010

E.C. approves Reyataz capsules for HIV-1 in pediatric patients

July 9, 2010

Chewable Lipitor obtains European approval for use in children

July 8, 2010

EC approves new indication for Orencia in rheumatoid arthritis

July 7, 2010

EMA completes validation of Dyax's MAA for ecallantide

July 7, 2010

Nycomed receives European marketing authorization for roflumilast in COPD

July 7, 2010

Circadin approved in the E.U. for 13-week treatment for primary insomnia

July 6, 2010

Rifapentine obtains orphan drug status in Europe for tuberculosis

July 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...